Cargando…

Stratification of patients in NASH clinical trials: A pitfall for trial success

Identifying the most effective therapeutic intervention in patients with NAFLD is challenging. Precise stratification in clinical trials is key to ensuring the inclusion of patients who will benefit (and not those who will be harmed) and/or in whom the natural history can be improved. Clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ampuero, Javier, Romero-Gomez, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486452/ https://www.ncbi.nlm.nih.gov/pubmed/32954243 http://dx.doi.org/10.1016/j.jhepr.2020.100148

Ejemplares similares

Non-Invasive Risk Stratification in NAFLD/NASH Patients for Screening EGD
por: Romano, John, et al.
Publicado: (2022)

Improved pathology reporting in NAFLD/NASH for clinical trials
por: Langford, Caitlin Rose, et al.
Publicado: (2022)

Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology
por: Calleja, José L., et al.
Publicado: (2022)

Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma
por: Udoh, Utibe-Abasi S., et al.
Publicado: (2022)

Missing data in clinical trials: Pitfalls and remedies
por: Kaushal, Sandeep
Publicado: (2014)

Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD
por: Ampuero, Javier, et al.
Publicado: (2022)

Pitfalls in Risk Stratification: The Case of Acute Pulmonary Embolism
por: Petretta, Mario, et al.
Publicado: (2023)

Patient-reported outcomes in NAFLD/NASH clinical trials: A blind spot that needs addressing
por: Sena, Elena, et al.
Publicado: (2022)

Enriching single-arm clinical trials with external controls: possibilities and pitfalls
por: Lambert, Jérôme, et al.
Publicado: (2022)

Self-induced class stratification in competitive societies of agents: Nash stability in the presence of envy
por: Gros, Claudius
Publicado: (2020)

Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?
por: Mereles, Derliz, et al.
Publicado: (2011)

From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
por: Gastaldelli, Amalia, et al.
Publicado: (2019)

Clinical trials using molecular stratification of pediatric brain tumors
por: Hanz, Samuel Z., et al.
Publicado: (2020)

Molecular Pathogenesis of NASH
por: Caligiuri, Alessandra, et al.
Publicado: (2016)

Surveillance for Hepatocellular Carcinoma in Patients with NASH
por: Kolly, Philippe, et al.
Publicado: (2016)

Future Pharmacotherapy for Non-alcoholic Steatohepatitis (NASH): Review of Phase 2 and 3 Trials
por: Connolly, James J., et al.
Publicado: (2018)

Correction to ‘Self-induced class stratification in competitive societies of agents: Nash stability in the presence of envy’
por: Gros, Claudius
Publicado: (2020)

Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do
por: Sanchez-Torrijos, Yolanda, et al.
Publicado: (2017)

Annual Bleeding Rates: Pitfalls of Clinical Trial Outcomes in Hemophilia Patients
por: Keipert, Christine, et al.
Publicado: (2020)

Challenges and Pitfalls: Performing Clinical Trials in Patients With Congenital Diaphragmatic Hernia
por: Cochius - den Otter, Suzan, et al.
Publicado: (2022)

Fragment-Based Screening by Protein Crystallography: Successes and Pitfalls
por: Chilingaryan, Zorik, et al.
Publicado: (2012)

The Emerging Role of Extracellular Vesicles and Autophagy Machinery in NASH—Future Horizons in NASH Management
por: Trifylli, Eleni-Myrto, et al.
Publicado: (2022)

Impact of a Novel Digital Therapeutics System on Nonalcoholic Steatohepatitis: The NASH App Clinical Trial
por: Sato, Masaya, et al.
Publicado: (2023)

Recreation of a hair follicle regenerative microenvironment: Successes and pitfalls
por: Abreu, Carla M., et al.
Publicado: (2021)

Noninvasive Diagnosis of NAFLD and NASH
por: Piazzolla, Valeria Annarita, et al.
Publicado: (2020)

Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment
por: Ilan, Yaron
Publicado: (2018)

The role of the microbiome in NAFLD and NASH
por: Kolodziejczyk, Aleksandra A, et al.
Publicado: (2018)

Pathophysiology of NASH in endocrine diseases
por: Gariani, Karim, et al.
Publicado: (2021)

Risk stratification in clinical trials: a subgroup to be encouraged
por: Clayton, Tim, et al.
Publicado: (2013)

Pilot trials in thrombosis: Purpose and pitfalls
por: Ikesaka, Rick, et al.
Publicado: (2018)

Systematic analysis of randomised controlled trials of Chinese herb medicine for non-alcoholic steatohepatitis (NASH): implications for future drug development and trial design
por: Chen, Xianwen, et al.
Publicado: (2023)

Editorial: Advances in systemic lupus erythematosus: The promises and pitfalls of personalized medicine and patient stratification
por: Marasco, Emiliano, et al.
Publicado: (2022)

Adaptive designs in clinical trials in critically ill patients: principles, advantages and pitfalls
por: van Werkhoven, C. H., et al.
Publicado: (2018)

Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies
por: Rojas, Ángela, et al.
Publicado: (2022)

Enrichment and Stratification for Predementia Alzheimer Disease Clinical Trials
por: Holland, Dominic, et al.
Publicado: (2012)

Immune and inflammatory pathways in NASH
por: Ganz, Michal, et al.
Publicado: (2013)

Pitfalls in clinical genetics
por: Chin, Hui-Lin, et al.
Publicado: (2023)

Patient stratification in clinical glaucoma trials using the individual tear proteome
por: Nättinen, Janika, et al.
Publicado: (2018)

Evolving Role for Pharmacotherapy in NAFLD/NASH
por: Attia, Suzanna L., et al.
Publicado: (2020)

Role of Hedgehog Signaling Pathway in NASH
por: Verdelho Machado, Mariana, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jbkmdklcm29ad95v0l4vmpk7jj